Latest Steven Nissen Stories

AHA Controversy Statins Recommendations
2013-11-19 14:50:13

Brett Smith for redOrbit.com - Your Universe Online Last week, the American Heart Association (AHA) and the American College of Cardiology (ACC) made significant waves when they released a set of recommendations for healthcare providers that suggested 33 million more Americans could benefit from cholesterol-lowering drugs called statins. This week, those recommendations are being called into question as a pair of Harvard Medical School professors published a report in the journal The...

Study Says Statins Are Safe
2013-07-10 13:49:13

Brett Smith for redOrbit.com - Your Universe Online A comprehensive study review has added to the growing body of evidence indicating the anti-inflammatory drugs known as statins have no significant side effects. The case for statin use is already strong, and some doctors are calling for its widespread use as a preventative regimen. Oxford University epidemiologist Rory Collins caused a stir last year with his presentation entitled, "The Case for Statins in a Wider Population" to the...

2010-07-22 07:50:00

Federal health authorities are prohibiting new patients from enrolling in a safety study for GlaxoSmithKline's controversial diabetes pill Avandia, a week after an expert panel ruled that the drug increases heart risks. The Associated Press (AP) reported Wednesday that the Food and Drug Administration (FDA) said it issued a "partial clinical hold" on the study to update researchers on the latest concerns about the drug, which has been under a close eye since 2007. Although the panel of...

2010-06-29 03:05:46

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The study was published online in advance of an upcoming Food and Drug Administration meeting that will review...

2008-12-18 08:40:06

Twenty-three million Americans suffer from Type 2 diabetes, and the FDA says it will now strictly screen the drugs created to treat the epidemic. Some believe the Food and Drug Administration's policy change will provide greater assurance of safety to doctors and patients, but it will make it more costly and time-consuming for companies to develop drugs that lower blood sugars. "I think the FDA got this one right," said Dr. Steven Nissen, a Cleveland Clinic cardiologist who raised the...

2008-11-13 09:05:00

New findings support the claim that a controversial diabetes pill failed to significantly slow plaque buildup in heart arteries compared with an older drug. Since May of last year, Avandia, once a blockbuster drug made by British-based GlaxoSmithKline PLC, has been under a dark cloud of doubt. That's because a medical journal report suggested it could raise the risk of heart attacks and heart-related deaths; the American Diabetes Association recently said patients should avoid using it...

2008-10-07 12:00:19

CALGARY, Oct. 7 /PRNewswire-FirstCall/ -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce the formation of the Steering Committee for the RVX-208 Phase 2b clinical trial assessing atherosclerosis by IVUS (Intravascular Ultrasound). This is a study in Acute Coronary Syndrome patients expected to start in 2009. "We are honored to have an experienced and highly esteemed group of internationally recognized cardiologists to lead this important IVUS...

2008-08-13 15:01:02

A wrongful death suit was filed against GlaxoSmithKline, SmithKline Beecham, and McKesson Corporation in California Superior Court, charging that Avandia, prescribed for Type 2 Diabetes, led to heart attacks, congestive heart failure and other fatal cardiovascular injuries in seven individuals. The suit, brought by Khorrami, Pollard & Abir and Kabateck Brown Kellner, LLP, was filed on behalf of the victims' seven surviving spouses, including Los Angeles, CA, and Costa Mesa, CA,...

2008-07-08 00:00:07

By Matthew Perrone WASHINGTON - Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under recommendations made Wednesday by a government panel. Advisers to the Food and Drug Administration voted 14-2 that all new diabetes drugs should undergo longer studies to assure they don't increase risks of heart problems. The opinions from diabetes experts, cardiologists and statisticians come less than a year after the FDA was criticized for...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.